Longitudinal Monitoring of Plasma Circulating Tumour DNA Enables the Prediction of Early Relapse in Patients with Non-Hodgkin Lymphoma: A Case Series

Growing evidence now suggests that circulating tumour DNA (ctDNA) has great potential as a non-invasive biomarker for disease monitoring, since ctDNA carries tumour-specific modifications. In particular, monitoring ctDNA has important implications for identifying patients with haematological maligna...

Full description

Bibliographic Details

Published in:	Diagnostics
Main Authors:	Hongyan Ji, Xiaolu Long, Jia Gu, Jin Jin, Xia Mao, Zhiqiong Wang, Heng Ma, Liting Chen
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Subjects:	B-cell non-Hodgkin lymphoma circulating tumour DNA liquid biopsy relapse droplet digital PCR
Online Access:	https://www.mdpi.com/2075-4418/11/11/2055